T&L Co Ltd (340570) Stock Price & News

Why is 340570 up 12.61%?

Dive Deeper

340570:KOSDAQ

T&L Co Ltd

₩25,900.00

+12.61%

(+2,900.00) 1D

Nov 13, 3:30:30 PM GMT+9 · KRW

All symbols

	Symbol	Price	Change	% Change

Generating top insights for 340570...

Open

₩23,100

High

₩26,800

Low

₩23,000

Mkt. cap

416.22B

Avg. vol.

48.04K

Volume

0.00

Dividend

2.90%

Quarterly dividend

₩188

Ex-dividend date

Dec 29, 2026

P/E ratio

8.19

52-wk high

₩35,800

52-wk low

₩21,550

EPS

₩3,162

Shares outstanding

16.07M

No. of employees

250

Open

₩23,100

High

₩26,800

Low

₩23,000

Mkt. cap

416.22B

Avg. vol.

48.04K

Volume

0.00

Dividend

2.90%

Quarterly dividend

₩188

Ex-dividend date

Dec 29, 2026

P/E ratio

8.19

52-wk high

₩35,800

52-wk low

₩21,550

EPS

₩3,162

Shares outstanding

16.07M

No. of employees

250

Related stocks

214450

PharmaResearch Co Ltd

News stories

From web sources and news partners

TradingView

5 hours ago

EXCLUSIVE: S&P 500’s Sell-Off Tested Buffered ETFs: Expert Explains Why a 10% Buffer May Not Protect You as Expected

24/7 Wall St.

1 hour ago

He Thinks His $200,000 S&P 500 401(k) Spreads His AI Risk. Two Alphabet Share Classes Put $10,380 in One Company. A 20% Drop Could Cost Him $2,076

Bloomberg.com

10 hours ago

SpaceX’s S&P 500 Bid Gets New Life as Musk Pitches Tesla Merger

Traders Union

5 hours ago

Michael Kantro: Institutional investors focus on stock picking as S&P 500 targets have lost relevance

About T&L Co Ltd

CEOYoon-so Choi

Employees250

Founded1998

Headquarters-

SectorHealth Care

IndustryMedical device

Websitetnl.co.kr

All values in KRW	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	40.67B	33.40B	45.07B	56.02B
Cost of goods sold	22.03B	20.80B	22.51B	26.10B
Cost of revenue	22.03B	20.80B	22.51B	26.10B
Research and development expenses	935.54M	2.12B	767.10M	852.46M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	5.12B	5.98B	3.07B	3.61B
Operating expense	6.51B	8.58B	4.29B	4.96B
Total operating expenses	28.53B	29.38B	26.80B	31.06B
Operating income	12.14B	4.02B	18.27B	24.96B
Other non operating income	156.77M	-149.57M	-55.85M	64.37M
EBT including unusual items	14.27B	3.73B	20.65B	26.54B
EBT excluding unusual items	14.13B	4.80B	20.65B	26.49B
Income tax expense	2.94B	675.00M	4.21B	6.59B
Effective tax rate	20.59%	18.09%	20.40%	24.83%
Other operating expenses	54.38M	60.40M	11.96M	8.77M
Net income	11.33B	3.06B	16.44B	19.95B
Net profit margin	27.86%	9.15%	36.48%	35.61%
Earnings per share	-	-	-	-
Interest and investment income	625.37M	267.60M	484.89M	600.55M
Interest expense	-2.74M	-3.34M	-2.35M	-828.36K
Net interest expenses	622.62M	264.25M	482.53M	599.72M
Depreciation and amortization charges	401.48M	398.07M	418.33M	482.84M
EBITDA	13.31B	5.23B	19.46B	26.23B
Gain or loss from assets sale	405.00K	93.78M	1.00K	-43.93M

Finance

Ask anything